In brief
CBRE Research reported that Singapore’s new private home sales fell 6.5% month over month to 203 units in October 2023, the third consecutive monthly decline. Sales in the first 10 months reached 5,532 units, down 17.7% year over year. With no new projects launched in October, sales came mainly from previously launched developments. CBRE attributed weaker demand to higher interest rates, economic uncertainty, cooling measures and increased buyer price sensitivity. The firm expects sales to remain subdued in the fourth quarter, although November activity may improve following launches including J’den and Hillock Green. CBRE Research forecasts 6,500–7,000 new private home sales for 2023 and expects full-year price growth of 3%, while saying a significant price correction is not expected absent broader economic stress.
Key takeaways
- October new private home sales declined 6.5% month over month to 203 units.
- Sales during the first 10 months of 2023 were 17.7% below the same period in 2022.
- CBRE Research cited higher rates, cooling measures and buyer price sensitivity as factors weighing on demand.
- The firm forecasts 6,500–7,000 new private home sales and 3% private home price growth for 2023.
November 15, 2023 -- In the absence of new launches, new private home sales continued to slump. New home sales fell for the third straight month, by 6.5% m-o-m from 217 units in Sep 2023 to 203 units in Oct 2023. This is the lowest monthly private home sales year to date, and lowest since Dec 2022’s 170 units. November should see better sales but unlikely to inspire as 2023 looks set to see the lowest new home sales since 2008.
On a y-o-y basis, new home sales were also down 35.4% y-o-y from the 314 units sold in Oct 2022.
With no new launch in Oct 2023, most sales were from previously-launched projects. This brings new home sales in the first 10 months of 2023 to 5,532 units, 17.7% y-o-y lower than the 6,723 units sold over the same period in 2022. Sentiment this year has clearly deteriorated with higher interest rates, softer economic prospects and two more rounds of cooling measures since.
Top 10 Selling Projects in Oct 2023 (including ECs and landed)
Source: CBRE Research, URA
The top performing project in the month was Lentor Hills Residences launched in September which sold another 24 units at a median price of S$2,116 psf. Following close behind was integrated development launched in May 2023 - The Reserve Residences which sold 23 units at a median price of S$2,361 psf. The third best-selling project was North Gaia EC which was launched in Apr 2022 and sold another 18 units in Oct 2023 to bring cumulative sales to 59%.
While sales at CCR projects were relatively slow, we note Klimt Cairnhill sold 11 units at a median price of S$3,509 psf, including a unit achieving the highest psf price in October of S$3,843psf. Myra, a freehold 85-unit project near Potong Pasir MRT, sold its last 4 units at a median price of $1,929 psf, and is now fully sold in three years after its first launch in Sep 2020.
New Home Sales (excl. ECs) by quantum
Source: CBRE Research, URA
*Based on Realis new sales (excl. EC) caveats extracted on 15 Nov 2023.
By market segment, Oct 2023’s developer sales (excluding ECs) were led by the Rest of Central Region (RCR) where 82 units (40.4%) were sold, followed by the Outside Central Region (OCR) where 76 (37.4%) units were sold and the Core Central Region (CCR) which saw the sale of 45 units (22.2%). This compares to 35.0% in the CCR, 32.7% in the RCR and 32.3% in the OCR in Sep 2023.
Based on quantum size, the largest proportion of new private homes sold (excl. ECs) were in the S$2.00 mil - S$2.50 mil range at 25.9%. This was followed by the S$3.00 mil – S$5.00 mil bracket at 23.4%.
Outlook
Year-to-Oct 2023 new home sales currently stand at 5,532 units, a 17.7% y-o-y fall from 6,723 units sold over the correspondingly period in 2022. CBRE Research is of the view that the souring macro backdrop, elevated interest rate hikes and cooling measures have resulted in increased buyer selectiveness and slower demand. This is evidenced by the slower take-up rate despite abundant new launches that came through from Jul – Aug 2023.
Slowdown in new launch take-up
In 2022, developers launched 15 new private residential projects with 4,528 units (excluding ECs) for sale. While this year to date, CBRE Research estimates that developers have already launched 19 private non-landed residential projects with a total of 6,815 units.
We believe the pent-up demand has been mostly absorbed and genuine buyers are now spoilt for choice. In addition, homebuyers have become more price sensitive amid the weaker economic backdrop and the slowdown in take-up at new launches could be reflective of resistance to the current high prices. Some of the projects which are targeted at investors or typically have higher foreigner buyers will face some resistance given the recent doubling in foreigners’ ABSD to 60% as well as a further increase in ABSD rate for investors. These investors will reassess their options and take a longer time to shop around.
Forecasts
November will be a better month for new home sales. It was reported that mixed-use development J’den (368 units), the redevelopment of the former JCube sold 88% of its total units at an average price of $2,451 psf, making it the best-selling new launch in 2023 in terms of proportion of units sold on its launch day, while Hillock Green (474 units) saw a take-up rate of 28% with an average price of $2,108 psf over their 11 – 12 Nov 2023 launch weekend. The robust performance at J’den is an indication that there is still ample liquidity on the sidelines for attractive launches at realistic price points.
Major launches that could be launched in the next few months are concentrated in the OCR, with projects such as Lentoria (265 units), Hillhaven (341 units) and Sora at Yuan Chin Road (440 units). The RCR could also see some launches – The Hill@one north (142 units) and Sky Botania (172 units) and the CCR could see the launch of Newport Residences (246 units).
Amid weaker sentiment, still-high interest rates and the upcoming December holiday season, developers might choose to push launches into 2024 when interest rates stabilise and sentiment improves. As such, developer sales are expected to remain subdued in Q4 2023.
Overall, CBRE Research expects 6,500 – 7,000 new private homes to be sold in 2023, potentially below the 7,099 units in 2022, which was already a 14-year low since 2008’s 4,264 units.
Correspondingly, CBRE Research believes home prices which have risen 3.9% cumulatively have peaked and are likely to be muted in Q4 2023. Barring widespread retrenchments and a sustained recession, a significant price correction is not expected given low unsold inventory and generally healthy household balance sheets. As such, CBRE Research maintains its full year 2023 forecast for private home price growth of 3%, slower than the 8.6% seen in 2022 due mainly to a weaker economic outlook -- MTI forecasts 0.5 – 1.5% GDP growth for 2023, vs 3.6% for 2022.
About CBRE Group, Inc.
CBRE Group, Inc. (NYSE:CBRE), a Fortune 500 and S&P 500 company headquartered in Dallas, is the world’s largest commercial real estate services and investment firm (based on 2022 revenue). The company has approximately 115,000 employees (excluding Turner & Townsend employees) serving clients in more than 100 countries. CBRE serves a diverse range of clients with an integrated suite of services, including facilities, transaction and project management; property management; investment management; appraisal and valuation; property leasing; strategic consulting; property sales; mortgage services and development services. Please visit our website at www.cbre.com.
If you detect any issues, problems, or errors in this press release content, kindly contact [email protected] to notify us (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). We will respond and rectify the situation in the next 8 hours.
Questions around this news
Why did Singapore new private home sales fall in October 2023?
The release attributes the slowdown to the absence of new project launches in October, alongside higher interest rates, weaker economic prospects and additional cooling measures. It reports 203 units sold, down from 217 in September, with most October sales coming from projects launched earlier.
What was the outlook for Singapore new home sales and prices in late 2023?
The release expected November sales to improve, partly due to strong launch-day interest in J’den, but forecast subdued developer sales in the fourth quarter. It also said prices were likely to be muted in that quarter and maintained a full-year 2023 forecast for private home price growth of 3%.
What is ABSD, and how can it affect homebuyers in Singapore?
Additional Buyer’s Stamp Duty (ABSD) is a tax charged on certain property purchases in Singapore, on top of the standard Buyer’s Stamp Duty. The rate can vary according to factors such as the buyer’s residency status and property ownership. A higher rate raises the upfront cost of buying and can influence purchasing decisions.
What do CCR, RCR and OCR mean in Singapore property-market reports?
These abbreviations refer to Singapore’s Core Central Region (CCR), Rest of Central Region (RCR) and Outside Central Region (OCR). They are geographic market segments used to classify residential property locations. Reports use them to compare activity and prices across central and more peripheral areas.
SEC filings
Earlier from CBRE Group, Inc.
- Freehold 3-storey Shophouse with value-add potential along Jalan Besar for sale via Public Tender
- 5 Ground-Level Commercial Units with permanent F&B and childcare approval along Jalan Jurong Kechil For Sale Via Expression Of Interest
- Adjoining Sites Summer Green and Kingsley Mansion in Balestier up for Collective Sale
- 3-Storey Conservation Shophouse along Joo Chiat Place For Sale Via Expression Of Interest
- Commentary on the Flash Estimate of Q3 2023 Private Residential Property Price Index